Needham Initiates LB Pharmaceuticals With Buy, $68 Target
Needham initiated coverage on LB Pharmaceuticals's stock with a rating of Buy and a price target of $68.00. The price target implies an upside of 82.4% from the Oct 1 close of $37.28.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.